REC Silicon - Private placement successfully completed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Lysaker, 14 October 2020.
Reference is made to the stock exchange release from REC Silicon ASA ("REC" or the "Company") published on 14 October 2020 regarding a contemplated private placement (the "Private Placement"). The Company is pleased to announce that it has raised approximately NOK 1,000 million in gross proceeds through the Private Placement of 92,592,592 new shares (the "New Shares"), at a price per share of NOK 10.80 (the "Offer Price"). The Private Placement took place through a process managed by Arctic Securities AS and Pareto Securities AS (the "Managers"). The Private Placement was substantially oversubscribed.
The net proceeds from the Private Placement will be used to fund expansion investments and activities at the Company’s facilities in Butte and Moses Lake as well as for general corporate purposes. Upon completion of the Private Placement, the Company will have established an extended liquidity runway which may enable the Company to prepare for a restart of the Moses Lake plant. Such restart is targeted in 2022 on the back of expected continuation of positive developments currently seen in both the solar energy and battery markets where the Company believes that it is positioned to become a leading US provider of silane and polysilicon.
The Private Placement consists of two separate tranches; one tranche with 27,982,000 New Shares in the Company (“Tranche 1”) and a second tranche with 64,610,592 New Shares ("Tranche 2"). Settlement for Tranche 1 is expected to be on or about 19 October 2020 (DVP, T+2), while settlement in Tranche 2 is expected to occur on or about 12 November 2020 following approval by an extraordinary general meeting in the Company of the issuance of the New Shares under Tranche 2 (the "EGM"). The investors who have been allocated New Shares have received a pro rata portion of shares from Tranche 1 and Tranche 2 based on their overall allocation in the Private Placement, with the exception of Aker Capital AS who has agreed that the New Shares it is allocated in the Private Placement will all be allocated in Tranche 2.
The delivery of New Shares will be settled with existing and unencumbered shares in the Company that are already listed on the Oslo Stock Exchange, pursuant to a share lending agreement between Arctic Securities AS (on behalf of the Managers), the Company and Aker Capital AS. Accordingly, the shares delivered to the investors will be tradable upon delivery, expected on or about 19 October 2020 in Tranche 1 and on or about 12 November 2020 in Tranche 2.
The completion of Tranche 1 is subject to approval by the Company's board of directors (the "Board") pursuant to an authorization granted by the Company’s annual general meeting held on 12 May 2020. The completion of Tranche 2 is subject to the approval of issuance of shares under Tranche 2 by the EGM. Completion of Tranche 1 is not conditional upon completion of Tranche 2, and acquisition of shares under Tranche 1 will remain final and binding and cannot be revoked or terminated by the respective applicants if Tranche 2 is not completed.
The share loan from Aker Capital AS will be settled with (i) new shares in the Company to be resolved issued by the Board pursuant to an authorisation granted by the Company’s annual general meeting held on 12 May 2020 (Tranche 1) and (ii) new shares in the Company to be issued following, and subject to, approval by the EGM (Tranche 2). The new shares re-delivered to Aker Capital AS in Tranche 2 will be issued on a separate ISIN and will not be tradable on the Oslo Stock Exchange until a listing prospectus has been approved by the Financial Supervisory Authority of Norway (the "Prospectus").
Subject to satisfaction of the conditions for completion of the Private Placement, the Board of the Company has resolved to propose that the EGM resolves to authorize the Board to carry out a subsequent offering of up to 18,518,518 new shares (the "Subsequent Offering") towards the Company's shareholders as of 14 October 2020 (as documented by the shareholder register in the Norwegian Central Securities Depository (VPS) as of the end of 16 October 2020, the "Record Date") who were not allocated shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful or, for jurisdictions other than Norway, would require any prospectus, filing, registration or similar action ("Eligible Shareholders").
The subscription price in the Subsequent Offering will be the same as the Offer Price in the Private Placement, i.e. NOK 10.80 per share. The Eligible Shareholders will receive non-transferrable subscription rights based on their shareholding as of the Record Date in the Subsequent Offering. Over-subscription with subscription rights is permitted, but subscription without subscription rights is not permitted. The Subsequent Offering will be conditional, inter alia, on (a) completion of the Private Placement, (b) approval of the authorization of the Board for the Subsequent Offering by the Company's shareholders at the EGM, and (c) approval and publication of the Prospectus by the Company. The Company will issue a separate stock exchange notice with further details on the Subsequent Offering when finally resolved.
The waiver of the preferential rights inherent in a private placement is considered necessary in the interest of time and successful completion. Taking into consideration the time, costs and expected terms of alternative methods of
the securing the desired funding, as well as the proposed Subsequent Offering, the Board has concluded that the completion of the Private Placement on the proposed terms at this time is in the mutual interest of the Company and its shareholders, and that the Private Placement complies with the equal treatment obligations under the Norwegian Securities Trading Act and the Oslo Stock Exchange's Circular no. 2/2014.
Arctic Securities AS and Pareto Securities AS are engaged as managers and joint bookrunners in the Private Placement and the Subsequent Offering. Advokatfirmaet Schjødt AS is acting as legal counsel to the Company
in connection with the Private Placement and the Subsequent Offering. Advokatfirmaet Thommessen AS is acting as legal advisor to the Managers in connection with the Private Placement and the Subsequent Offering.
For further information, please contact:
James A. May II, Chief Financial Officer
Phone: +1 509 989 1023
Nils O. Kjerstad
Phone: +47 9135 6659
About the Company:
REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine over 30 years of experience and proprietary technology with the needs of our customers, with annual production capacity of more than 20,000 MT of polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock Exchange (ticker: REC), the Company is headquartered in Lysaker, Norway. For more information, please visit: www.recsilicon.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This announcement is not and does not form a part of any offer to sell, or a solicitation of an offer to purchase, any securities of the Company. Copies of this announcement are not being made and may not be distributed or sent into any jurisdiction in which such distribution would be unlawful or would require registration or other measures.
The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and accordingly may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any part of the offering in the United States or to conduct a public offering of securities in the United States. Any sale in the United States of the securities mentioned in this announcement will be made solely to "qualified institutional buyers" as defined in Rule 144A under the Securities Act.
In any EEA Member State, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Regulation, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. The expression "Prospectus Regulation" means Regulation (EU) 2017/1129 as amended (together with any applicable implementing measures in any Member State.
This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only for relevant persons and will be engaged in only with relevant persons. Persons distributing this communication must satisfy themselves that it is lawful to do so.
Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "strategy", "intends", "estimate", "will", "may", "continue", "should" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believe that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict, and are beyond their control. Actual events may differ significantly from any anticipated development due to a number of factors, including without limitation, changes in public sector investment levels, changes in the general economic, political and market conditions in the markets in which the Company operates, the Company's ability to attract, retain and motivate qualified personnel, changes in the Company's ability to engage in commercially acceptable acquisitions and strategic investments, and changes in laws and regulation and the potential impact of legal proceedings and actions. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not make any guarantee that the assumptions underlying the forward-looking statements in this announcement are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this announcement or any obligation to update or revise the statements in this announcement to reflect subsequent events. You should not place undue reliance on the forward-looking statements in this announcement.
The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this announcement.
Neither the Managers nor any of their affiliates makes any representation as to the accuracy or completeness of this announcement and none of them accepts any responsibility for the contents of this announcement or any matters referred to herein.
This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities of the Company. Neither the Managers nor any of its affiliates accepts any liability arising from the use of this announcement.
The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Galapagos increases share capital through subscription right exercises4.12.2020 22:01:00 CET | Press release
Mechelen, Belgium; 4 December 2020, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises. Galapagos issued 70,925 new ordinary shares on 4 December 2020, for a total capital increase (including issuance premium) of €2,615,857.50. Pursuant to the subscription right exercise program of Galapagos’ management board, members of the management board automatically are committed to exercise a minimum number of subscription rights, subject to certain conditions. In accordance with the rules of this program, CEO Onno van de Stolpe exercised 15,000 subscription rights. Three other management board members exercised an aggregate number of 15,000 subscription rights. In accordance with Belgian transparency legislation1, Galapagos notes that its total share capital currently amounts to €353,819,443.97, the total number of securities conferring voting rights amounts to 65,411,767, which is also the total
REC Silicon - Approval and publication of prospectus4.12.2020 20:39:33 CET | Press release
Lysaker, 4 December 2020. Reference is made to the stock exchange announcements by REC Silicon ASA (the "Company") on 14 October 2020 and 15 October 2020 regarding the successful completion of a private placement raising gross proceeds of approximately NOK 1,000 million (the "Private Placement"). A prospectus for listing of the 92,592,592 new shares in the Company issued in connection with the Private Placement was approved by the Financial Supervisory Authority of Norway on 4 December 2020. The prospectus and a summary of the prospectus will be available at the Company's website www.recsilicon.com. For further information, please contact: James A. May II, Chief Financial Officer Phone: +1 509 989 1023 Email: firstname.lastname@example.org Nils O. Kjerstad IR Contact Phone: +47 9135 6659 Email: email@example.com About the Company: REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries wor
Novartis announces first data from REACH3 trial showing Jakavi® (ruxolitinib) significantly improved outcomes in patients with steroid-resistant/dependent chronic GvHD4.12.2020 18:30:00 CET | Press release
Results of REACH3trial also demonstratesignificant improvements in failure-free survival (FFS) and patient-reported symptoms1Chronic graft-versus-host disease (GvHD) is a life-threateningcomplication ofstem cell transplants and half of patients become steroid refractory/dependent2,3Findingsfrom the study were presented at ASH 2020,and complement previouslyreported positive results for Jakavi in acute GvHD; data to be submitted to ex-U.S. health authorities4 Basel, December4, 2020 — Detailed results from the pivotal Phase III REACH3 study demonstrate Jakavi® (ruxolitinib) significantly improved outcomes across a range of efficacy measures in patients with steroid-refractory/dependent chronic graft-versus-host disease (GvHD) compared to best available therapy (BAT)1. The results of REACH3, the first successful, randomized Phase III trial in chronic GvHD, were presented today during the 62nd American Society of Hematology Annual Meeting & Exposition (ASH). REACH3 is jointly sponsored by N
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS4.12.2020 16:20:00 CET | Press release
Bid procedure, 2020-12-10BondsDANSKE HYPOTEK AB: 2312. SE0011116474. 2023-12-20 LANSFORSAKRINGAR HYPOTEK: 516, SE0009190390, 2023-09-20 NORDEA HYPOTEK AB: 5533, SE0010442731, 2023-09-20 SKANDINAVISKA ENSKILDA: 576, SE0010049841, 2023-12-20 SWEDISH COVERED BOND: 144., SE0011167428, 2023-06-21 STADSHYPOTEK AB: 1588, SE0011063015, 2024-03-01 SWEDBANK HYPOTEK AB: 193, SE0011089622, 2023-12-20 Bid date2020-12-10Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)2312: 300 mln SEK +/-150 mln SEK 516: 600 mln SEK +/-300 mln SEK 5533: 1000 mln SEK +/-500 mln SEK 576: 800 mln SEK +/-400 mln SEK 144.: 600 mln SEK +/-300 mln SEK 1588: 1200 mln SEK +/-600 mln SEK 193: 1000 mln SEK +/-500 mln SEK Maximum 5500 mln in totalHighest permitted bid volume (corresponding nominal amount)2312: 300 mln SEK per bid 516: 600 mln SEK per bid 5533: 1000 mln SEK per bid 576: 800 mln SEK per bid 144.: 600 mln SEK per bid 1588: 1200 mln SEK per bid 193: 1000 mln SEK per bid
CONDITIONS FOR RIKSBANK BID PROCEDURE KOMMUNINVEST BONDS4.12.2020 16:20:00 CET | Press release
Bid procedure, 2020-12-08BondsKOMMUNINVEST I SVERIGE: 2311. SE0010948240. 2023-11-13 KOMMUNINVEST I SVERIGE: 2611, SE0012569572, 2026-11-12 BidsBids on interest and volume are entered via Bloomberg Bond Auction SystemBid date2020-12-08Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)2311: 1000 mln SEK +/-250 mln SEK 2611: 1000 mln SEK +/-250 mln SEK Maximum 2000 mln in totalHighest permitted bid volume (corresponding nominal amount)2311: 1000 mln SEK per bid 2611: 1000 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNo later than 11.10 (CET/CEST) on the Bid dateDelivery and payment date2020-12-10Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383General Terms and ConditionsGeneral Terms and Conditions General Terms and Conditions för the Riksbank’s Purchases of Bonds via Bid Procedure 2020:3. dated 20 November 2020
CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS4.12.2020 16:20:00 CET | Press release
Bid procedure, 2020-12-11BondsSWEDISH GOVERNMENT: 1060. SE0009496367. 2028-05-12 SWEDISH GOVERNMENT: 1062, SE0013935319, 2031-05-12 Bid date2020-12-11Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)1060: 1500 mln SEK +/-250 mln SEK 1062: 1500 mln SEK +/-250 mln SEK Maximum 3000 mln in totalHighest permitted bid volume (corresponding nominal amount)1060: 1500 mln SEK per bid 1062: 1500 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNo later than 10.10 (CET/CEST) on the Bid dateDelivery and payment date2020-12-15Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2020-12-04 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Com
Klövern offentliggör preliminärt utfall i företrädesemission4.12.2020 16:00:00 CET | Pressemelding
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, JAPAN, AUSTRALIEN, HONGKONG, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA ELLER NÅGON ANNAN JURISDIKTION DÄR SÅDAN ÅTGÄRD INTE SKULLE VARA FÖRENLIG MED TILLÄMPLIGA LAGAR OCH FÖRESKRIFTER. YTTERLIGARE RESTRIKTIONER ÄR TILLÄMPLIGA. SE AVSNITTET ”VIKTIG INFORMATION” I SLUTET AV DETTA PRESSMEDDELANDE. Teckningsperioden i Klövern AB:s (publ) (”Klövern” eller ”Bolaget”) företrädesemission avslutades den 3 december 2020. Det preliminära utfallet visar att företrädesemissionen är övertecknad. Genom företrädesemissionen kommer Klövern att tillföras cirka 2 miljarder kronor före emissionskostnader. Det preliminära utfallet visar att 17 103 861 stamaktier av serie A och 186 435 270 stamaktier av serie B tecknades med stöd av teckningsrätter, motsvarande 98,6 procent av antalet erbjudna stamaktier av serie A respektive 98,7 procent av antalet erbjudna stamaktier av serie B. Därtill har tecknings